A clinical trial for peanut allergy treatment has hit another milestone, with research suggesting graduated doses of peanut protein powder could help protect allergic children.

U-M researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: extended relief from peanut allergies.

The results suggest that graduated doses of peanut protein powder could help protect against the consequences of accidental allergen exposure.

The firestorm of controversy surrounding the epinephrine auto-injector’s rising prices raises additional issues about the U.S. pharma market.